Impact of Standing Orders Optimization

Running, not enrolling · Not applicable

Conditions studied: Human Papilloma Virus

In brief

This trial will look at the impact of optimizing human papillomavirus (HPV) vaccine standing orders. The research team will work with primary care clinics. Some clinics will receive communication training. Other clinics will receive the same training and tools for increasing the use of their standing orders.

Key facts

Study ID

NCT05742386

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

27

Starts

2023-02-22

Expected to finish

2026-12-31

Last updated by the study team

2026-04-21

Who can join

Age: 9 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinics are eligible if they:
• provide HPV vaccine to children ages 9-12
• have standing orders for HPV vaccination approved but not routinely used or be willing to adopt them prior to the start of the trial
• have rates of HPV vaccination (≥1 dose) below 72%, boys and girls combined
• Children's medical records will be eligible to be included in the dataset if children:
• are between the ages of 9-12 years at baseline
• are attributed to a participating clinic at 12- or 24-month follow-up
• Clinical staff's survey data will be eligible to be included in the dataset if clinical staff complete the follow-up survey.

You may not qualify if…

• Clinics are excluded if they:
• do not provide HPV vaccine to children ages 9-12
• do not have standing orders for HPV vaccination or are not willing to adopt them prior to the start of the trial
• have rates of HPV vaccination (≥1 dose) above 72%, boys and girls combined
• have hosted an AAT workshop in the previous 3 years or are part of current HPV vaccine communication trainings
• have quality improvement efforts to change HPV vaccine standing orders during the trial
• Children's medical records will not be eligible to be included in the dataset if children:
• are not between the ages of 9-12 years at baseline
• are not attributed to a participating clinic at 12- or 24-month follow-up
• are receiving hospice/palliative care, are pregnant, or have a history of HPV vaccine contraindications
• Clinical staff's survey data will be not eligible to be included in the dataset if clinical staff do not complete the follow-up survey.

Where it is running

• The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.